Comment · Fri, November 2, 2012 · Ceretropic
Cephalon/Teva owns a patent for Modafinil that lasts until 2024. Could this slow down generics?
Original post in this thread
mjtribute · 10 points
According to the FDA's Orange Book, these are the two patents which cover Cephalon's Modafinil 100mg:
RE37516 (expires 2015) and 7297346 (expires 2024).
Cephalon/Teva have litigated vigorously over Modafinil, going as far as acquiring competitors and paying large sums of money in settlements to delay the release of generics as long as possible.
Of course, we have Modalert (Modafinil) and Wakalert (Armodafinil) from the Indian firm Sun Pharma. But as far as American pharmaceuticals are concerned, don't these patents listed above stand in the way of additional Modafinil g…
What they were answering
johns8 · 2 points
Pardon my ignorance, but if a layman chemist synthesized these bad boys and sold them over the internet, will he get in shit?
I'm tired.
u/MisterYouAreSoDumb · Ceretropic
If you sold them, probably. I depends on where you live. The precursors are not monitored like those for other substances, though. I'm sure Cephalon would be on your ass very quickly if you had a US storefront selling their patented product.